{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:42:27Z","timestamp":1792057347299,"version":"4.4.0"},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast J"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1111\/tbj.13064","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T03:26:19Z","timestamp":1526959579000},"page":"190-195","source":"Crossref","is-referenced-by-count":17,"title":["Chemoprevention acceptance and adherence in women with high-risk breast lesions"],"prefix":"10.1155","volume":"25","author":[{"given":"Constance A","family":"Roche","sequence":"first","affiliation":[{"name":"Division of Surgical Oncology; Massachusetts General Hospital; Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5727-1010","authenticated-orcid":false,"given":"Rong","family":"Tang","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology; Massachusetts General Hospital; Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3125-1139","authenticated-orcid":false,"given":"Suzanne B","family":"Coopey","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology; Massachusetts General Hospital; Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S","family":"Hughes","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology; Massachusetts General Hospital; Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"10.1111\/tbj.13064-BIB0001|tbj13064-cit-0001","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/00313020802568097","article-title":"Update on atypical epithelial hyperplasia and ductal carcinoma in\u00a0situ","volume":"41","author":"Simpson","year":"2009","journal-title":"Pathology"},{"key":"10.1111\/tbj.13064-BIB0002|tbj13064-cit-0002","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease","volume":"312","author":"Dupont","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.13064-BIB0003|tbj13064-cit-0003","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.13064-BIB0004|tbj13064-cit-0004","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO.2006.09.0217","article-title":"Stratification of breast cancer risk in women with atypia: a Mayo Cohort Study","volume":"25","author":"Degnim","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/tbj.13064-BIB0005|tbj13064-cit-0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(03)12230-1","article-title":"Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study","volume":"361","author":"Page","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/tbj.13064-BIB0006|tbj13064-cit-0006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","article-title":"Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study","volume":"7","author":"Hartmann","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1111\/tbj.13064-BIB0007|tbj13064-cit-0007","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-012-2318-8","article-title":"The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions","volume":"136","author":"Coopey","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/tbj.13064-BIB0008|tbj13064-cit-0008","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1524-4741.1999.00002.x","article-title":"Lobular carcinoma in\u00a0situ of the breast","volume":"5","author":"Frykberg","year":"1999","journal-title":"Breast J"},{"key":"10.1111\/tbj.13064-BIB0009|tbj13064-cit-0009","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejso.2011.01.009","article-title":"Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast: a review","volume":"37","author":"Hussain","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1111\/tbj.13064-BIB0010|tbj13064-cit-0010","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","article-title":"Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease","volume":"22","author":"Page","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1111\/tbj.13064-BIB0011|tbj13064-cit-0011","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000478-197809000-00001","article-title":"Lobular carcinoma in\u00a0situ of the breast. Detailed analysis of 99 patients with average follow-up of 24\u00a0years","volume":"2","author":"Rosen","year":"1978","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/tbj.13064-BIB0012|tbj13064-cit-0012","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T","article-title":"Lobular neoplasia (so-called lobular carcinoma in\u00a0situ) of the breast","volume":"42","author":"Haagensen","year":"1978","journal-title":"Cancer"},{"key":"10.1111\/tbj.13064-BIB0013|tbj13064-cit-0013","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for the prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/tbj.13064-BIB0014|tbj13064-cit-0014","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/tbj.13064-BIB0015|tbj13064-cit-0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","article-title":"Update of the National Surgical Adjuvant Breast and Bowel Project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer","volume":"3","author":"Vogel","year":"2010","journal-title":"Cancer Prev Res"},{"key":"10.1111\/tbj.13064-BIB0016|tbj13064-cit-0016","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.13064-BIB0017|tbj13064-cit-0017","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","author":"Cuzick","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/tbj.13064-BIB0018|tbj13064-cit-0018","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"key":"10.1111\/tbj.13064-BIB0019|tbj13064-cit-0019","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","article-title":"Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Visvanathan","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1111\/tbj.13064-BIB0020|tbj13064-cit-0020","unstructured":"National Comprehensive Cancer Network Breast Cancer (Version 1.2017) 2016"},{"key":"10.1111\/tbj.13064-BIB0021|tbj13064-cit-0021","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-159-10-201311190-00718","article-title":"Medications for risk reduction of primary breast cancer in women: US Preventive Services Task Force recommendation statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1111\/tbj.13064-BIB0022|tbj13064-cit-0022","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","article-title":"Patient decisions about breast cancer chemoprevention: a systematic review and metaanalysis","volume":"28","author":"Ropka","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/tbj.13064-BIB0023|tbj13064-cit-0023","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10549-012-2089-2","article-title":"Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010","volume":"134","author":"Waters","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/tbj.13064-BIB0024|tbj13064-cit-0024","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/1940-6207.CAPR-10-0100","article-title":"The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemoprevention","volume":"3","author":"Ravdin","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1111\/tbj.13064-BIB0025|tbj13064-cit-0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ypmed.2004.09.041","article-title":"Factors affecting breast cancer risk reduction practices among California physicians","volume":"41","author":"Kaplan","year":"2005","journal-title":"Prev Med"},{"key":"10.1111\/tbj.13064-BIB0026|tbj13064-cit-0026","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/JOP.2010.000107","article-title":"Implementation in a large health system of a program to identify women at high risk for breast cancer","volume":"7","author":"Owens","year":"2011","journal-title":"J Oncol Pract"},{"key":"10.1111\/tbj.13064-BIB0027|tbj13064-cit-0027","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/annonc\/mdv590","article-title":"Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis","volume":"27","author":"Smith","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1111\/tbj.13064-BIB0028|tbj13064-cit-0028","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/tbj.12418","article-title":"Breast cancer chemoprevention among high-risk women and those with ductal carcinoma in\u00a0situ","volume":"21","author":"Reimers","year":"2015","journal-title":"Breast J"},{"key":"10.1111\/tbj.13064-BIB0029|tbj13064-cit-0029","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/cncr.20205","article-title":"Acceptance of tamoxifen chemoprevention by physicians and women at risk","volume":"100","author":"Tchou","year":"2004","journal-title":"Cancer"},{"key":"10.1111\/tbj.13064-BIB0030|tbj13064-cit-0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.breast.2014.11.006","article-title":"Acceptance and adherence to chemoprevention among women at increased risk of breast cancer","volume":"24","author":"Roetzheim","year":"2015","journal-title":"Breast"},{"key":"10.1111\/tbj.13064-BIB0031|tbj13064-cit-0031","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/bjc.2014.109","article-title":"Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic","volume":"110","author":"Donnelly","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1111\/tbj.13064-BIB0032|tbj13064-cit-0032","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","author":"Breast International Group (BIG) 1-98 Collaborative Group","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.13064-BIB0033|tbj13064-cit-0033","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1200\/JCO.2013.51.2483","article-title":"Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer","volume":"32","author":"Maunsell","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1111\/tbj.13064-BIB0034|tbj13064-cit-0034","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1002\/cncr.24508","article-title":"Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism","volume":"115","author":"Hernandez","year":"2009","journal-title":"Cancer"}],"container-title":["The Breast Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftbj.13064","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tbj.13064\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T17:31:01Z","timestamp":1751650261000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tbj.13064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"URL":"https:\/\/doi.org\/10.1111\/tbj.13064","archive":["Portico"],"relation":{},"ISSN":["1075-122X"],"issn-type":[{"value":"1075-122X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,21]]}}}